Please select the option that best describes you:
What is your preferred regimen for a patient with clear cell RCC, progression after an IO+IO regimen, with a chronic non-healing wound?
Would you consider HIF2a or TKI? If TKI, would you consider short acting TKI like axitinib vs preferred 2L TKI cabozantinib?